Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» pomalidomide
pomalidomide
Celgene says phase III study of pomalidomide combo met primary endpoint
Yahoo/Fly on the Wall
Thu, 09/5/13 - 08:26 am
Celgene
pomalidomide
Multiple Myeloma
Keep an Eye on These Five New Drugs in the First Quarter of 2013
Minyanville
Thu, 12/27/12 - 10:16 pm
Rytary
GSK
Impax Labs
Celgene
pomalidomide
Roche
T-DM1
Immunogen
Eliquis
Pfizer
Bristol-Myers Squibb
Biogen Idec
BG-12
Celgene Investors: What to Watch
Motley Fool
Sun, 12/16/12 - 10:19 am
Celgene
pomalidomide
Multiple Myeloma
Celgene's Momentum Continues
Motley Fool
Wed, 12/12/12 - 08:06 am
Celgene
pomalidomide
Multiple Myeloma
Celgene’s Pomalidomide Helps in Myeloma After Others Fail
Bloomberg
Tue, 12/11/12 - 10:22 am
Celgene
pomalidomide
ONYX Pharmaceuticals
Multiple Myeloma
Revlimid Ramp-Up, New Drug Launches Make Celgene a Buy
Motley Fool
Thu, 11/29/12 - 11:05 am
Revlimid
Celgene
Vidaza
Abraxane
apremilast
pomalidomide
Celgene International Sarl Releases Results of Phase II Study on Multiple Myeloma Patients
Trading Markets
Sat, 06/12/10 - 10:14 am
Cellgene
Multiple Myeloma
dexamethasone
pomalidomide
lenalidomide